跳至主要内容
临床试验/JPRN-UMIN000013771
JPRN-UMIN000013771
已完成
未知

Feasibility study of Epirubicin-Eluting-Bead Embolization for Hepatocellular Carcinoma (JIVROSG-1301) - Feasibility study of DEB-epiDOX for HCC (JIVROSG-1301)

Japan Interventional Radiology In Oncology Study Group(IVROSG)0 个研究点目标入组 8 人2014年4月23日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Hepatocellular carcinoma
发起方
Japan Interventional Radiology In Oncology Study Group(IVROSG)
入组人数
8
状态
已完成
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2014年4月23日
结束日期
2014年9月30日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
Japan Interventional Radiology In Oncology Study Group(IVROSG)

入排标准

入选标准

  • 未提供

排除标准

  • 1\) Prior surgical reconstruction or endoscopic treatment of the biliary tract 2\) Clinically significant refractory ascites or pleural effusion 3\) Severe arterio\-portal or arterio\-venous shunts in the liver 4\) Allergy to contrast medium that precludes angiography 5\) Severe, active co\-morbidity, defined as follows: \- Uncontrolled cardiac failure, angina and/or rhythm disorders \- Myocardial infarction within the last 6 months \- Renal failure \- Active infection (viral hepatitis is allowed) \- Active gastrointestinal bleeding \- Other active malignant tumor \- Hepatic encephalopathy or severe mental disorder 6\) Pregnancy, nursing women, or women of childbearing potential, and men who are sexually active and not willing or able to use medically acceptable forms of contraception 7\) Not eligible because of safety issues judged by investigators

结局指标

主要结局

未指定

相似试验